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Thirty two novel 1,3-diarylpropenones (chalcones) have been synthesised by Claisen-Schmidt
condensation. Twenty six of them are new compounds and have been fully characterised from their
spectral data. The structures of five chalcones have also been confirmed by X-ray crystallography.
Twenty one differently substituted chalcones have been tested against the invasion of human MCF-7/6
mammary carcinoma cells, five chalcones have been found to exhibit potent anti-invasive activity. Seven
out of thirty two chalcones synthesised show herbicidal activity of interest.
1,3-Diarylpropenones (chalcones) constitute an
important group of natural products and some of
them possess a wide range of biological activities
such as antibacterial'"; antifungal'<", antiinflam-
matory'i'" antimicrobiaI9,1l-15, antitumour'",
anticancer 17,1 8, prostaglandin binding" and insect
antifeedant'". They also find use in the production
of nematic liquid crystals'? and photosensitive
polymers" and as antioxidants for oils22-26• Certain
prenylated (3-methylbut-2-eny-lated) chalcones
isolated from Sophora subprostrata have been
studied in polorus-ligated, stress-induced ulcers in
rat and found to possess potent inhibitory action
on ulcer formation27,28. A di-O-prenylated chalcone
1 synthesised by Kyogoku et 01.29 is a clinical
candidate for the treatment of ulcer. We have
earlier synthesised a large number of pyrano-
chalcones'" the cyclic analogues of prenylated
chalcones and some of these chalcones were found
to possess moderate to good antimicrobial,
antiviral", anti-invasive32 and antiinsecticidal "
activities. Further, chalcones are precursors of
flavones. The anti-invasive activity of flavones is
well documented'Y". Our earlier anti-invasive
activity examination of differently substituted
flavones has revealed that 3,7 -dimethoxyflavone is
an an attractive molecule because of its activity
over a broad range of concentration (1-1 00 ~
without showing signs of cytotoxicity'". Flavone
acetic acid, a compound of the same family is an
anti-tumor agent against murine adenocarcinoma
cells in vivo and this compound has underwent
phase I and II clinical trials35-37• Encouraged. by
these findings, we have synthesised thirty two
differently substituted chalcones 2-33. Twenty six
of these are hitherto unknown compounds. The
structures of five of the novel chalcones have been
confirmed by X-ray crystallography. Twenty one
chalcones, 2,3,6, 8-10, 12, 14-22,24,25,27,29
and 31 have been tested for their anti-invasive
activity against solid tumours and five of them (2,
3, 9, 12 and 24) were found to possess anti-
invasive activity. In preliminary screening, seven
chalcones (2, 3, 6, 9 and 29-31) exhibited potent









herbicidal activity, while 19 and 39 were found to
be insecticidal against cotton aphid at 500 ppm
concentration.
Synthesis of chalcones. The chalcones 2-33
were synthesised by the base-catalysed Claisen-
Schmidt reaction of the appropriate acetophenones
and benzaldehydes in varying yields (50-75%)
(Schemes I and II). For example, chalcone 2 was
synthesised in four steps, starting with the Friedel-
Craft's coupling of resorcinol with glacial acetic
acid followed by permethylation and prenylation,
and the resulting resacetophenone on condensation
with benzaldehyde in the presence of Ba(OH)2 in
ethanol afforded the chalcone 2 in 72% yield
o
2 R1=Pr, R2=R3=R.=R5=Re=H
3 R,=Pr, R2=R3=~=Re=H, R5=CH(CH3n
•• R1=Pr, R2=R3=~=Re=H, Rs=OC2HS
5 R1=Pr, R2=R3=~=Re=H, Rs=CI
6 R1= Pr, R2=R3:;Rs=Re=H, R4=OPh
7 R1=Pr, R2=R3=Rs=Re=H, ~=N02
8 R1=Pr, R2=R3=~=Re=H, Rs=N02
9 R,=Pr, R2=R3=Re=H,--R4=R-s=OCH3
10 R1=Pr, R2=~=Re=H, R3=Rs=OCH3
11 R,=Pr, R2=~=Rs=H, R3=Re=OCH3







(Scheme I). Similarly, the ditetrahydropyrano-
chalcone 14 was synthesised by the Hoesch
condensation of phloroglucinol with acetonitrile,
followed by diprenylation, cyc\isation of the
prenyl groups with vicinal phenolic hydroxyl
groups and finally by condensation of the resultant
ditetrahydropyranoacetophenone with· 4-methyl-
benzaldehyde in the presence of Ba(OH)2 in




2-b: 3, 4-b']dipyrab39 36, 5~benzhydryl-2-hydroxy-
4-methoxy-acetophenone4o 37, ~-resacetophe-
630 INDIAN J CHEM, SEC.B, nJL Y 1998
R,

























PARMAR et of. : SYNTHESIS & ANTI-INVASIVE ACTIVITY OF 1,3-DIARYLPROPENONES 631







H~0'6:;pr OCH;, H3c0xX;pr OCH3
+ I '-': + I '-':






(i) glacialCH~OOH, fusedZnCI2,heatedto 135·C;
(ii) (CH31~04' anhydronsK~03, dry acetone,reflux;
(iiQ butene-2-.0I,dioxane,BF3-Et~, RT, stirring1hr,
(iv) benzaldehyde,fusedBa\OHh, ethanol,reflux
Synthesis of C-S' prenylated chalcones
none" and 2-benzyloxy-4-methoxyacetophenone42
and the aldehyde, 7-benzyloxy--6=formyl-2,2-di:·
methyldihydrobenzo[ 1,2-b [pyran'" 38 were pre-
pared by methods reported in literature and
characterised on the basis of their spectral data.
Other aldehydes, such as benzaldehyde, 4-
isopropylbenzaldehyde, 4-ethoxybenzaldehyde, 4-
chlorobenzaldehyde, 3-phenoxybenzaldehyde, 3-
nitro- and 4-nitrobenzaldehydes, 3,4-dimethoxy-,
2,4-dimethoxy- and 2,5-dimethoxybenzaldehydes,
2-methyl-, 3-methyl- and 4-methylbenzaldehydes
and 4-methoxybenzaldehyde were procured from
Fluka Chemika-Biochemica Chemical Company,
Switzerland. 3,4-Dimethoxyacetophenone and 3-
benzyloxy-4-methoxybenzaldehyde were procured
from Aldrich Chemical Company, USA. The
chalcones 2-33 can be classified among three
major categories on the basis of their substituents
in ring-A; (a) compounds 2-13 having a prenyl (3-
methylbut-2-enyl) group; (b) compounds 1-4=19
having cyclized 3-methylbut-2-enyl group(s), i.e.
Scheme I
tetrahydrodipyrano- and dihydropyranochalcones,
and (c) compounds 20-33 having methoxy,
hydroxy, benzhydryl and benzyloxy groups as
substituents in ring-A. Compounds 2-18 and 20-28
are new and were identified on the basis of their
MS, IR, UV, IH and l3CNMR spectral analyses,
Though the compounds 29-33 have been
synthesised earlier42•44-47 their complete spectral
data have not been reported, and we therefore
,report all the data for these compounds (cf
; Experimental). The known chalcone 19 was
identified by comparison of its spectral data with
those reported".
X-Ray Crystallography
The structures determined on the basis of
spectral analysis of the tetrahydrodipyrano-
chalcone 14, dihydropyranochalcone 19 and the
3',4'-dimethoxychalcones 23, 28 and 29 were
-confirmed by X-ray crystallography. Schematic
representations of the molecular structures of the
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(Q CH3CN, fused ZnCI2, dry ether, dry HCI gas, O··C;
(ii) butene-2-ol, dioxane, BF3"Et~, RT, stirring 1hr;
(iil) H-COOH,100·C, O.5hr,
(tv) 4-methylbenzaldehyde, fused Ba(OHJ2, ethanol, reflux
Synthesis of ditelrahydropyranochalcones
Scheme n
chalcones 14, 19, 23 and 29 are shown in Figures
1-4, respectively; the structure of 28 has been
reported elsewhere48.
Blologlcal activities of chalcones
Out of the thirty two chalcones(2-33)
synthesised, twenty one [sevenS'Csprenylated (2,
3, 6, 8-10 and 12), five tetrahydrodipyrano (14-
18), one dihydropyrano (19), three benzhydrylated
(20-22) and five 3',4'-dimethoxychalcones (24, 25,
27, 29 and 31)] were tested for their possible in
vitro anti-invasive activity, The assay of anti-
invasive activity was based on confrontation of
invasive human MCF-7/6 mammary carcinoma
cell line on embryonic chick heart fragments". In
such confronting cultures, .effect of the tumour
cells can be seen on the normal host tissue. Human
MCF-7/6 breast carcinoma cells were selected as
'test cells because they are invasive in this assay
Figure l-Crystal structure of 9-hydroxy-1O-(4'-methyl-
cinnamoyl)-2, 2, 6,6-tetramethyltetrahydrobenzo[1,2-b: 3, 4-b']-
dipyran 14
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Figure 2-Crystal structure of 6-(2,4-dimethoxycinnamoyI)-7-hydroxy-2,2-dimethyldihydrobenzo[ 1,2-b ]pyran 19
Figure 3-Crystal;structure of 1-[(3',4'-dimethoxy)phenyl]-3-[(2-methyl)phenyl]propenone 23
Figure 4---Crystal structure of 1-[(3',4'-dimethoxy)phenyl]-3-[( 4-methoxy)phenyl]propenone 29
and have earlier been shown to be sensitive to the
effect of a number of flavonoids32,50.52. Anti-
invasive activity of chalcones was determined at
three different concentrations, 100, 10 and 1 f.!.M
(Table I). Five chalcones out of twenty one, viz 2,
3, 9, 12 and 24 exhibited activity at different
concentration levels. Among the three categories
of chalcones tested, i.e. prenylated, pyrano- and
methoxychalcones, only those compounds having
the prenyl group in ring-A, i.e. 1-(2',4'-dimethoxy-
5'-prenylphenyl)-3-phenylpropenone 2, 1-(2',4'-di-
methoxy-5'- prenylphenyl)-3-( 4- isopropylphenyl)-
propenone 3, 1-(2', 4'-dimethoxy-5'-prenylphenyl)-
3-(3, 4-dimethoxyphenyl)propenone 9 and 1-(2',4'-
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moyl)-2,2,6,6-tetramethyltetrahydrobenzo[ 1,2-b: 3,
4-b']dipyran 14, 9-hydroxy-l 0-(4'-isopropylcinna-
moyl)-2',2,6,6-tetramethyl-tetrahydrobenzo[1,2-b: 3,
4-b']dipyran 15, 9-hydroxy-2,2,6,6-tetramethyl-l0-
(3'-phenoxycinnamoyl) tetrahydrobenzo[1, 2-b: 3,
4-b']dipyran 16, 9-hydro~y-2,2,6,6-tetramethyl-l 0-
(3'-mtrocinnamoyl) tetrahydrobenzo-j l, 2-b: 3, 4-
b']dipyran 17 and 10-(3'-benzyloxy-4'-methoxycin-
namoyl)-9-hydroxy-2, 2,6,6-tetramethyltetrahydro-
benzo[I,2-b: 3,4-b']dipyran 18 or pyranochalcone
19 did not exhibit anti-invasive activity, at all.
However, our earlier anti-invasive activity
investigation on cyclic analogues of prenylated
chalcones has revealed that the chalcones 40 and
41 are active at 10 J.LM concentration". The only
difference in these two chalcones and
pyranochalcones under present investigation is the
presence of hydroxy function at C-3 position of the
heterocyclic ring. This indicates that the hydroxy
function at appropriate position in the
pyranochalcones induces anti-invasive activity in
the molecule. Among the eight chalcones with no
prenyl substitution in ring-A only one com-pound,
i.e. 3-(4-methoxyphenyl)-I-(3',4'-dimethoxy-phenyl)-
dimethoxy-5'-prenylphenyl)-3-(7-benzyloxy 2,2-di- propenone 29 was found to inhibit invasion of
methyl-dihydrobenzopyran-6-yl)propenone12, exhi- MCF-7/6 carcinoma cells on normal cells at 100
bited anti-invasive activity except 1-(3',A'-dimethoxy- J.LM concentration. Other seven chalcones, i.e. 1-
phenyl)-3-(4-methylphenyl)propenone 24 belong- (2'-hydroxy-5'-benzhydryl-4'-methoxyphenyl)-3-(4-
ing to category (c). Out of seven 5'-prenylated ethoxyphenyl)propenone 20, 1-(2'-hydroxy-5'-benz-
compounds 2, 3, 6, 8-10 and 12 of category (a) hydryl-4'-methoxyphenyl)-3-(3-phenoxyphenyl)pro-
tested for anti-invasive activity, four compounds penone 21, 1-(2'-hydroxy-5'-benzhydryl-4'-methoxy-
were found to be active at different concentration phenyl)-3-(3-nitrophenyl)propenone 22, 1-(3', 4'-di-
levels. Among these four active compounds, 1- methoxyphenyl)-3-(4-methylphenyl)propenone 24,
(2',4'-dimethoxy-5'-prenylphenyl)-3-phenylpropenone 1-(3',4'-dimethoxyphenyl)-3-(4-isopropylphenyl)pro-
2 with unsubstituted B-ring was found to be the penone 25, 1-(3',4'-dimethoxyphenyl)-3-(4-nitro-
most potent compound by exhibiting activity even phenyl)propenone 27 and 1-(3',4'-dimethoxy-
at 1 J.LM concentration. Anti-invasive activity of phenyl)-3-(3-phenoxyphenyl)propenone 31 did not
I
prenylated chalcones decreased on substitution in exhibit anti-invasive activity at any of the three test
the B-ring with alkyl, methoxy, phenoxy and nitro concentrations. The X-ray crystallographic studies
groups or fused pyrano ring. Thus, chalcones 3, 9 on five of our compounds, i.e. the chalcones 14,
and 12 exhibited anti-invasive activity only at 100 19,23,28 and 29 indicate that the geometry across
and 10 J.LM concentrations and no appreciable the double bond is trans and the same is expected
activity was observed at 1 J.LM concentration. for the remaining chalcones studied in this paper.
Prenylated chalcones 6, 8 and 10 do not exhibit I The coupling constant between two olefinic
any appreciable activity even at 100 J.LM protons in different chalcones studied in this paper
concentration. The activity of prenylated is in the range 15.5-16.0 Hz, which is also
chalcones was lost completely when the prenyl indicative of the fact that the geometry across the
I group(s) was cyclised to pyrano ring, i.e. double bond is trans in all cases. It is a well-
dipyranochalcones, 9-hydroxy-l 0-(4'-methylcinna- established fact that naturally occurring chalcones































































+ : anti-invasive; - : not anti-invasive; 0 : not tested
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have trans-configurations3. Thus, the present anti-
invasive activity of chalcones is with reference to
their trans-geometry. The results of activity testing
clearly indicate that the prenyl group at the C-5'
position of chalcones is necessary for their anti-
invasive activity. In preliminary screening, seven
chalcones, 2, 3, 6, 9 and 29-31, exhibited potent
herbicidal activity in a mini-screening system,
while the dihydropyranochalcone 19 and its 3,4-
dehydro derivative 39 were found to be
insecticidal against cotton aphid at 500 ppm
concentration. Detailed work on herbicidal and
insecticidal activity evaluation of these chalcones
is in progress.
Conclusion
The present synthesis and screening of
differently substituted chalcones against invasive
human MCF-7/6 mammary carcinoma cells has led
to the identification of a prenylated chalcone
effective at inhibiting the invasion of cancer cells
on normal cells even at I J.iM concentration.
Though the breakthrough for a suitable and safe
drug for the treatment of different types of cancers
and to stop the inherent tendency of tumour cells
to migrate beyond their natural tissue boundries is
still to come, 1-(2',4'-dimethoxy-5'-prenylphenyl)-
3-phenylpropenone 2 could prove to be a lead
compound for further studies. Furthermore, as
chalcones constitute an important group of natural
products, the synthesis and spectral details of a
variety of cha1cones contained in this paper will
allow future identification of new cha1cones.
Experimental Section
General. Melting points were determined in a
sulphuric acid-bath and are uncorrected. EI mass
spectra were recorded on a Varian Mat 311 A or
Jeol AX 505 W mass spectrometer at 70 eV. IH
and IJC NMR spectra were recorded in CDC13 at
250 and 62.9 MHz, respectively on a Bruker AC-
250 spectrometer using TMS as internal standard.
Coupling constants(J) are in Hz. IR (film / nujol)
and UV (MeOH) spectra were recorded on a
Shimadzu model 435 and a Beckman DU-2
spectrophotometer, respectively. Analytical TLCs
were performed on precoated E Merck silica gel
60 F254 aluminium plates.
General procedure for the formation of 1,3-
diarylpropenones 2-33: Claisen-Schmidt con-
densation of acetophenones with aldehydes. The
appropriately substituted acetophenone (5 rnmoles)
was dissolved in ethanol (30 mL) and fused
Ba(OHh (2 g) was added, followed by the
addition of a solution of the corresponding
aldehyde (5 rnmoles) in ethanol (5 mL). The
reaction mixture was stirred in an ice-bath and the
reaction monitored by TLC. Ice-cold water (50
mL) was added to the reaction mixture and the
reddish-yellow residue that separated out was
filtered, washed with water (2 x 50 mL), dried and
purified by silica gel column chromatography
(solvent system: ethyl acetate-petroleum ether in
varying proportions). Crystallization afforded
yellow crystalline/gummy 1,3-diarylpropenones 2-
33 in yields of 50-75%.
1-(2',4' -Dimethoxy-5' -prenylphenyl)-3-phenyl-
propenone 2. Mp 69-72°C ; ElMS (reI. int.): mlz
336(M+, 100), 321(14), 308(12), 281(9), 267(8),
233(23), 217(10), 205(18), 160(6), 140(6),
131(65), 103(23), 91(8) and 77(13); IH NMR:
8 1.70 and 1.72(2s, 3H each, 2xCH3), 3.25(d, J =
6.7, 2H, CHrCH=), 3.91 and 3.93(2s, 3H each,
2xOCH3), 5.27(t, J = 6.7, IH, CHrCH=), 6.45(s,
IH, H-3'), 7.37-7.40(m, 3H, H-3, H-4 and H-5),
7.53(d, J= 15.9, IH, H-a), 7.58-7.61(m, 3H, H-2,
H-6 and H-6') and 7.68(d, J = 15.9, IH, H-(3);
I3C NMR: 8 17.7 and 25.7(2xCH3, 27.6(CH2' 55.5
and 56.0(2xOCH3), 94.7(C-3'), 120.9(CH2-CH=),
122.0(C-a), 122.7(C-l'), I27.2(C-6'), 128.1 and
128.7(C-2, C-3, C-5 and C-6), I29.7(C-4),
131.8[ =C(CH3)2], 132.5(C-I), 135.5(C-5'), 141.5
(C-I3), 159.0(C-2'), 161.6(C-4') and 190.5 (C=O);
IR : 2950, 1650, 1620, 1580, 1260, 1240, 1120,
1020, 820 and 770 ern"; UV : 207,230,295 and
335(sh) nm.
1-(2', 4'-Dimethoxy-5'-prenylphenyl)-3-( 4-iso-
propylphenyl)propenone 3. Mp 95-96°C; ElMS
(reI. int.): mlz 378(M+, 100), 363(13), 350(22),
335(15), 309(11), 245(17), 233(18), 205(12),
173(10) and 131(24); IH NMR: 8 1.25[d, J= 7.0,
6H, CH(CH3)2], 1.70 and 1,72(2s, 3H each,
2xCH3), 2.93[h, J = 7.0, 1H, CH(CH3)2], 3.26(d,
J= 7.2, 2H, CHrCH=), 3.91 and 3.92(2s, 3H each,
2xOCH3), 5.27(t, J = 7.2, IH, =CH-CH2), 6.45(s,
IH, H-3'), 7.24(d, J = 8.1, 2H, H-3 and H-5),
7.48(d, J = 15.7, IH, H-a), 7.51(m, IH, H-6'),
7.55(d, J = 8.1, 2H, H-2 and H-6) and 7.66(d,
J = 15.7, IH, H-(3); I3C NMR: 8 17.6(CH3),
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23.7 [CH(CH3)2], 25.7(CH3), 27.6(CH2), 33.9
[(CH3)2CH], 55.4 and 55.9(2xOCH3), 94.8(C-3'),
121. 1(=CH-CH2), 122. 1(C-a), 122.6(C-l'), 125.9
(C-5'), 126.4(C-6'), 126.8(C-2 and C-6), 128.2(C-3
and C-5), 129.5(C-4), 132.5(C-l), 133.1[=C
(CH3)2], 141.7(C-~), 158.9(C-2'), 161.4(C-4') and
190.7(C=O); IR : 2950,' 1645, 1615, 1580, 1270,
1125, 1020,980 and 820 em"; UV : 207,233 and
315 nm.
1-(2', 4'- Dimethoxy-S'- prenylphenyl)- 3- (4-
ethoxyphenyljpropenene 4. Mp 87°C; ElMS (reI.
int.): m/z 380(M+,100), 365(25), 352(33), 311(38),
245(21), 233(21), 217(21), 175(39), 162( 19),
147(21), 135(73), 119(12), 107(9), 91(9) and
69(7); IH NMR: 8 1.41(t, J= 7.0, 3H, CHrCH3),
1.70 and 1.71(2s, 3H each, 2xCH3), 3.26(d, J =
7.0, 2H, CHrCH=), 3.89 and 3.90(2s, 3H each,
2xOCH3), 4.05(q, J = 7.0, 2H, OCH2), 5.27(t, J =
7.0, 1H, =CH-CH2), 6.44(5, 1H, H-3'), 6.88(d, J =
8.5, 2H, H-3 and H-5), 7.40(d, J= 15.7, 1H, H-a),
7.52(d, J = 8.5, 2H, H-2 and H-6), 7.56(5, 1H, H-
6') and 7.64(d, J = 15.7,__1H, H-(3); 13CNMR : 8
14.6(CH2CH3), 17.6 and 25.7(2xCH3), 27.6(CH2-
CH=), 55.4 and 56.0(2xOCH3), 63.5(OCH2), 94.9
(C-3'), 114.7(C-3 and C-5), 121.3(C-1 '), 122.2
(C-a), 122.6(C-5'), 125.0(=CH-CH2)' 128.0(C-1),
129.8(C-2 and C-6), 131.7(C-6'), 132.4(=C(CH3)z),
141.7(C-(3), 158.8(C-2'), 160.5(C-4'), 161.4(C-4)
and 190.6(C=O); IR : 2975, 164Q,1605, 1570,
1505, 1260, 1170, 1020 and 830 ern"; UV : 205,
233 and 345 nm.
1-(2', 4'- Dimethoxy-S'- prenylphenyl)- 3- (4-
chlorophenyl)propenone S. Mp 94°C; ElMS (reI.
int.): mlz 370/372(M+/M++2, .100/33), 3551357
(40113), 245(20), 233(21), 217/219(2217), 205(30),
1651167(72/24) and 137(16); IH NMR: 8 1.70 and
1.72(25, 3H each, 2xCH3), 3.25(d, J = 7.2, 2H,
-CHrCH=), 3.90 and 3.92(2s, 3H each, 2xOCH3),
5.27(t, J = 7.2, 1H, =CH-CH2), 6.44(s, 1H, H-3'),
7.34(d, J = 8.4 , 2H, H-3 and H-5), 7.50(d, J =
15.6, 1H, H-a), 7.51(d, J= 8.4, 2H, H-2 and H-6),
7.58(s, 1H, H-6I]--and-+.-60(d,...[ =_J5.~ 1H, H-(3);
13 -- - - - -
C NMR: 8 17.7 and 25.7(2xCH3), 27.6
(CH2CH=), 55.5 and 56.0(2xOCH3), 94.8(C-3'),
120.9(C-1'), 122. 1(C-a), 122.9(C-5'), 127.9(CHr
CH=), 129.0(C-3 and C-5), 129.3(C-2 and C-6),
130.7(C-4), 131.9(C-6'), 134.1(C-1), 135.5
(=C(CH3)2), 139.9(C-(3), 159.1(C-4'), 161.8(C-2')
and 190. 1(C=O); IR (KBr) : 3500, 2950, 1655,
1625, 1585, 1500, 1345, 1320, 1270, 1250, 1210,
1130, 1090, 1020, 980 and 885 em"; UV : 206,
229,308 and 350(sh) nm.
1-(2' , 4' -Dimethoxy-S' -prenylphenyl)-3-(3-phe-
noxyphenyl)propenone 6. Gummy mass; ElMS
(reI. int.): m/z 428(M+, 100), 400(18), 373(12),
359(8),233(43),205(21), 115(12), 102(13), 77(24)
and 41(25); IH NMR : 8 1.69 and 1.71(2s, 3H
each, 2xCH3), 3.25(d, J= 7.2, 2H, CH2-CH=), 3.88
and 3.92(25, 3H each, 2xOCH3), 5.26(t, J = 7.2,
IH, =CH-CH2), 6.43(s, IH, H-3'), 7.05(d, J = 2.0,
IH, H-2), 7.31-7.39(m, 10H, H-4, H-5, H-6, H-6',
H-a and C6HS) and 7.54(d, J= 15.5, 1H, H-B); 13C
NMR : 8 17.6 and 25.7(2xCH3), 27.6(CH2), 55.5
and 55.9(2xOCH3), 94.9(C-3'), 117.4(C-4), 119.1
(C-2" and C-6"), 119.9(CH2-CH=), 121.4(C-l'),
122.0(C-2), 122.7(C-a), 123.3(C-5), 123.5(C-6),
127.9(C-1), 129.7(C-3 II and C-5"), 130.0(C-6'),
131.8[=C(CH3)2], 132.5(C-5'), 137.4(C-4"), 140.6
(C-(3), 156.6(C-1 "), 157.7(C-3), 159.0(C-2'),
161.7(C-4') and J90.2(C=O); IR(KBr): 1660,
1620, 1580, 1500, 1280, 1200, 1120, 1020, 980,
750 and 690 em"; UV : 213 and 298 nm.
1-(2', 4'- Dimethoxy-S'- prenylphenyl)- 3- (3-
nitrophenyl)propenone 7. Mp 166°C; ElMS (reI.
int.): mlz 381(M+,100), 366(32), 364(36), 351(12),
326(10), 233(20), 217(16), 205(28), 176(84),
146(10), 129(9) and 102(9); IH NMR : 8 1.70 and
1.73(2s, 3H each, 2xCH3), 3.26(d, J = 7.2, 2H,
CHrCH=), 3.92 and 3.96(2s, 3H each, 2xOCH3),
5.27(t, J = 7.2, 1H, =CH-CH2), 6.46(5, 1H, H-3'),
7.56-7.60(m, 4H, H-2, H-4, H-a and H-(3), 7.85(d,
J = 7.6, IH, H-6), 8.20(d, J = 7.6, IH, H-5) and
8.44(s, 1H, H-6'); 13C NMR: 8 17.7 and 25.8
(2xCH3), 27.6(CH2), 55.6 and 56.1 (2xOCH3),
94.7(C-3'), 120.4(C-l'), 122.0(C-a), 123.1(C-5'),
123.9(C-2 and C-6), 124.7(C-4), 130.2(C-5),
132.1 (=CH-CH2), 132.7[=C(CH3)2], 134.1 (C-6'),
137.5(C-1), 138. 1(C-(3), 148.7(C-3), 159.5(C-2'),
162.2(C-4') and 189.4(C=O); IR: 2950, 1660,
1620, 1590, 1535, 1360, 1350, 1270, 1240, 1140,
1020, 820 and 725 em"; UV : 207, 235, 284 and
355 nm.
1-(2', 4'- Dimethoxy-S'- prenylphenyl)- 3- (4-
nitrophenyl)propenone 8. Mp '164°C; ElMS (reI.
int.): mlz 381(M+, 100),366(14),351(7),326(11),
248(16), 233(44), 205(21), 191(10), 176(54),
151(10), 130(8), 102(8) and 77(8); IH NMR : 8
.1.70 and 1.72(25, 3H each, 2xCH3), 3.26(d, J =
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7.3, 2H, CH2-CH=), 3.92 and 3.95(2s, 3H each,
2xOCH3), 5.27(t, J = 7.3, 1H, CHrCH=), 6045(s,
1H, H-3'), 7.62-7.69(m, 3H, H-6', H-a and H-I3),
7.71(d, J = 8.2, 2H, H-2 and H-6) and 8.24(d, J =
8.2, 2H, H-3 and H-5); l3C NMR : 0 17.7 and
25.7(2xCH3), 27.6(CHrCH=), 55.5 and 56.0
(2xOCH3), 94.7(C-3'), 12004(C-1'), 122.0(C-a),
123.2(C-5'), 124.0(C-2 and C-6), 128.6(C-3 and C-
5), 129.7[=C(CH3)2], 131.3(=CH-CH2)' 132.1(C-
6'), 137.9(C-I3), 142.0(C-1), 148.1(C-4), 159.5(C-
4'), 162.3(C-2') and 189.3(C=O); IR : 2950, 1660,
1620, 1520, 1320, 1260, 1240, 1200, 1180, 1120,
1020,980, 840, 820, 760 and 720 ern"; UV : 203,
215(sh), 313 and 345(sh) nm.
1-(2', 4'- Dimethoxy-5'- preoylpheoyl)-3-(3,4-
dimethoxyphenyl)propenone .9. Mp 85-87°C;
ElMS (reI. int.): mlz 396(M+, 100), 381(15),
368(21), 341(13), 327(26), 245(10), 233(18),
191(37), 165(13) and 151(57); IH NMR : 0 1.69
and 1.71(25,3H each, 2xCH3), 3.24(d, J= 7.5, 2H,
CH2-CH=), 3.91(s, 12H, 4xOCH3), 5.26(t, J= 7.5,
1H, CH2-CH=), 6045(s, IH, H-3'), 6.86(d, J = 7.8,
IH, H-5), 7.11(m, IH, H-2), 7.18(d, J = 7.8, 1H,
H-6), 7.36(d, J= 15.9, IH, H-a), 7.54(s, IH, H-6')
and 7.61(d, J = 15.9, IH, H-I3); l3CNMR :0 17.6
and 25.7(2xCH3), 27.6(CHrCH=), 5504, 55.7,
55.9, 56.0(4xOCH3), 194.8(C-3'), 110.0(C-2),
1l0.9(C-5), 121.l(C-1), 122.1(CH2-CH=), 12204
(C-a), 122.6(C-1'), 125.3(C-6), 12804(C-6'), 131.7
[=C(CH3)2]' 132.5(C-5'), 141.9(C-I3), 148.9(C-3),
150.7(C-4), 158.7(C-2'), 161.3(C-4') and 190.0
(C=O); IR: 2950, 1650, 1605, 1580, 1520, 1240,
1120, 1020, 810 and 720 ern"; UV : 207, 233,
300(sh) and 355 nm.
1-(2', 4'-Dimethoxy-5'- prenylpheoyl)-3-(2, 4-
dimethoxypheoyl)propeoooe . 10. Mp 76°C;
ElMS (reI. int.): mlz 396(~, 17), 365(100),
.327(9),233(13), 191(11), 165(11) and 151(24); IH
NMR : 0 1.69 and 1.70(2s, 3H each, 2xCH3),
3.26(d, J = 7.0, 2H, CH2-CH=), 3.77, 3.83, 3.85
and 3.90(4s, 3H each, 4xOCH3), 5.27(t, J = 7.0,
IH, =CH-CH2), 6044(gr5, 2H, H-3 and H-3'),
6.51(dd, J = 8.0 and 3.0, 1H, H-5), 7046(d, J =
16.0, IH, H-a), 7.54(m, 2H, H-2 and H-6') and
7.93(d, J = 16.0, 1H, H-I3); l3C NMR: 0 17.6 and
25.7(2xCH3), 27.6(CH2-CH=), 55.3, 5504 and
56.0(4xOCH3), 94.9(C-3'), 98.2(C-3), 105.1(C-5),
117.6(C-1), 121.6(C-1'), 122.2(C-a), 12204(CH2-
CH=), 125.5(C-6), 130.0(C-6'), 131.7[=C(CH3)2],
13204(C-5'), 13704(C-I3), 158.6(C-2), 159.9(C-4),
161.0(C-2'), 16204(C-4') ami 191.3(C=O); IR:
2950, 1645, 1615, 1570, 1310, 1270, 1200, 1125,
1020, 980 and 820 ern"; UV : 207, 240, 300(5h)
and 365 nm.
1-(2', 4'- Dimethoxy-5'-prenylphenyl)-3-(2, 5-
dimethoxyphenyl)propenone 11. Mp 84°C;
ElMS (reI. int.): mlz 396(M+, 15), 365(68),
248(23), 233(36), 191(19), 166(100), 165(A9),
149(48) and 123(20); IH NMR: 0 1.69 and
1.72(25, 3H each, 2xCH3), 3.27(d, J = 7.2, 2H,
CH2-CH=), 3.80, 3.84 and 3.93(3s, 12H, 4xOCH3),
5.26(t, J = 7.2, IH, =CH-CH2), 6044(5, 1H, H-3'),
6.82-6.94(m, 2H, H-3 and H-4), 7.16(d, J = 3.0,
1H, H-6), 7.60(d, J = 15.5, 1H, H-a), 7.63(s, 1H,
H-6') and 7.94(d, J = 15.5, 1H, H-I3); l3C NMR:
s 17.7 and 25.7(2xCH3), 27.6(CH2-CH=), 55.5,
55.7,55.9 and 56.0(4xOCH3), 95.0(C-3'), 11204(C-
3), 113.5(C-4), 116.3(C-a), 121.3(C-1), 122.2(C-
6), 122.6(C-1'), 125.3(=CH-CH2)' 128.1(C-6'),
131.9 (C-5'),. 132.5[=C(CH3)2], 136.9(C-I3),
153.1(C-2), 15304(C-5), 158.9(C-4'), 161.4(C-2')
and 191.0(C=O); IR: 2950, 1650, 1615, 1270,
1200, 1120, 1020 and 720 ern"; UV: 207, 260, 310
and 365 nm.
1-(2', 4'- Dimethoxy-5'-preoylpheoyl)-3-(7-
benzyloxy-2, 2-dimethyl-dihydrobenzopyrao - 6-
yl)-propeoooe 12. Semisolid; ElMS (reI. int.): mlz
526(M+,10), 435(6), 419(57), 379(8), 296(8),
233(58), 193(15), 105(15) and 91(100); IH NMR:
s 1.34(5, 6H, 2xCH3), 1.69 and 1.70(2s, 3H each,
2xCH3), 1.80(t, J = 6.5, 2H, H-3), 2.73(t, J = 6.5,
2H, H-4), 3.24(d, J= 7.0, 2H, CH2-CH=), 3.75 and
3.90(25, 3H each, 2xOCH3), 5.07(s, 2H, OCH2Ph),
5.26(t, J = 7.0, IH, =CH-CH2), 6040(5, 2H, H-8
and H-3'), 7.26-7049(m, 8H, H-a, H-5, H-6' and
C6H5) and 7.97(d, J= 15.5, IH, H-[3); l3CNMR:o
17.7, 25.7 and 26.8(4xCH3), 21.5(C-3), 27.6(CH2-
CH=), 32.7(C-4), 5504 and 55.8(2xOCH3),
70.1(OCH2), 75.2(C-2), 95.1(C-3'), 101.4(C-8),
117.l(C-6), 121.8(=CH-CH2)' 122.3(C-a), 124.8
(C-l'), 125.3(C-5'), 127.1(C-4a), 127.2(C-6' and C-
5), 127.7(C-3" and C-5"), 128.1(C-2" and C-6"),
12804(C-4,i), 131.6[=C(CH3)2], 136.7(C-1"), 13804
(C-[3), 15604(C-4'), 157.6(C-2', C-7 and C-8a) and
190.6(C=O); IR (KBr) : 1660, 1620, 1570, 1500,
1440, 1280, 1200, 1120, 1020, '980, 750 and 700
em"; UV : 2.07,258, 310(sh) and 375 nm.
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1-(2', 4'- Dimethoxy-3'- prenylphenyl)- 3- (4-
ethoxyphenyl)propenone 13. Semi solid; ElMS
(reI. int.): m/z 380(M", 54), 365(38), 311(18),
245(18), 233(13), 217(100), 189(19), 175(21),
163(34), 135(58) and 119(10); IH NMR: 0 1.41(t,
J = 7.0, 3H, CH3), 1.69 and 1.79(25, 3H each,
2xCH3), 3.40(d, J= 6.8, 2H, ·CH2-CH=), 3.69 and
3.87(28, 3H each, 2xOCH3), 4.05(q, J = 7.0, 2H,
OCH2), 5.19(t, J= 6.8, 1H, =CH-CH2), 6.79(d, J=
8.7, 1H, H-5'), 6.89(d, J = 8.7, 2H, H-3 and H-5),
7.40(d, J= 15.7, 1H, H-a), 7.55(d, J= 8.7, 2H, H-
2 and H-6), 7.58(d, J= 8.7, IH, H-6') and 7.70(d, J
= 15.7, IH, H-(3); \3C NMR: 0 14.6, 17.8 and
25.6(3xCH3), 22.7(CH2-CH=), 55.7(OCH2), 62.9
and 63.5(2xOCH3), 106.2(C-3'), 114.7(C-3 and C-
5), 122.6(C-a), 123.8(C-l), 123.9(=CH-CH2)'
126.3(C-l'), 127.7(C-5'), 129.5(C-6'), 130.l(C-2
and C-6), 131.5[=C(CH3)2], 143.1(C-13), 158.8(C-
4), 160.8(C-4'), 161.3(C-2') and 191.6(C=O).
9-Hydroxy-l0-(4'-methylcinnamoyl)-2,2, 6, 6-
tetramethyltetrahydrobenzo[ 1,2-b: 3,4-b']dipy-
ran 14. Mp 134-35°C; ElMS (reI. int.): m/z
406(M", 100),351(42),335(11),315(28),295(33),
288(40), 259(18), 233(33), 217(17), 190(20),
177(54), 14P(12), 117(13) and 91(11); IHNMR:o
1.35 and 1.42(28, 6H each, 4xCH3), 1.79(t, 4H, J =
6.8, H-3 and H-7), 2.38(8, 3H, Ar-CH3), 2.55(t, J =
6.8, 2H, H-4), 2.64(t, J= 6.8, 2H, H-8), 7.20(d, J=
8.0, 2H, H-3' and H-5'), 7.45(d, J = 8.0, 2H, H-2'
and H-6'), 7.70(d, J = 15.5, IH, H-a), 8.02(d, J =
15.5, IH, H-(3)and 14.50(8, IH, chelated OH); \3C
NMR: 0 16.1 and 16.5(C-3 and C-7), 21.3(Ar-
CH3), 26.9(4xCH3), 31.8 and 32.0(C-4 and C-8),
75.3 and 75.7(C-2 and C-6), 100.4 and 100.6(C-4a
and C-8a), 105.4(C-l 0), 127.5(C-a), 128.0(C-2'
and C-6'), 129.5(C-3' and C-5'), 133.2(C-4'),
139.9(C-l'), 140.8(C-13), 154.2(C-9), 158.5(C-
lOa), 163.3(C-4b) and 192.8(C=O); IR: 3420,
2930, 1620, 1540, 1415, 1160, 1105, 1070, 980,
880 and 710 ern"; UV: 205, 210(8h) and 358 nm.
9-Hydroxy-l0-( 4'- isopropylcinnamoyl)-2,2,6,
6-tetramethyltetrahydrobenzo[I,2-b: 3,4-b']dipy-
ran 15. Mp 138°C; ElMS (reI. int.): mlz
434(M",100), 379(27), 315(25), 288(44), 259(15),
233(27),217(12) and 177(39); IH NMR : 0 1.27[d,
J = 7.7, 6H, CH(CH3)2], 1.35 and 1.43(28, 6H
each, 4xCH3), 1.79(t, J = 6.8, 4H, H-3 and H-7),
2.56(t, J = 6.8, 2H, H-4), 2.66(t,.l = 6.8, 2H, H-8),
2.97[m, IH, CH(CH3)2], 7.24(d, J = 8.0, 2H, H-3'
and H-5'), 7.53(d, J = 8.0, 2H, H-2' and H-6'),
7.70(d, J = 15.5, IH, H-a), 8.07(d, J = 15.5, 1H,
H-(3) and 14.53(8, IH, chelated OH); \3C NMR:
s 16.2 and 16.6(C-3 and C-7), 23.8[CH(CH3)2],
26.9(4xCH3), 31.9 and 32.1(C-4 and C-8),
34.l(>CH), 76.2 and 76.3(C-2 and C-6), 100.2 and
100.4(C-4a and C-8a), 105.2(C-I0), 126.9(C-3' and
C-5'), 127.6(C-a), 128.0(C-l'), 128.3«C-2' and C-
6'), 133.4(C-4'), 141.0(C-13),151.2(C-9), 154.7(C-
4b and C-I0a) and 189.2(C=O); IR: 3420, 2920,
1716, 1617, 1551, 1150, 1110, 985, 827 and 670
em"; UV: 205, 210(8h) and 358 nm.
9-Hydroxy-2,2,6,6-tetramethyl-lO-(3' -phenoxy-
cinnamoyl)4etrahydrobenzo[l, 2-b: 3, 4-b']dipy-
ran 16. Mp 135-36°C; ElMS (reI. int.): m/z
484(M", 100), 483(18), 429(27), 373(23), 315(47),
288(14), 259(24), 233(16), 217(13) and 177(38);
IH NMR: 0 1.29 and 1.34(28, 6H each, 4xCH3),
1.73-1.80(m, 4H, H-3 and H-7), 2.52(t, J = 6.8,
2H, H-4), 2.63(t, J = 6.8, 2H, H-8), 6.98-7.41(m,
9H, H-2', H-4', H-5', H-6'and OC6H5), 7.67(d, J =
15.5, IH, H-a), 7.98(d, J = 15.5, IH, H-(3) and
14.40(8, IH, chelated OH~; \3C NMR: 0 16.1 and
16.5(C-3 and C-7), 26.9(4xCH3), 31.8 and 32.1(C-
4 and C-8), 75.5 and 75.9(C-2 and C-6), 100.5 and
100.7(C-4a and C-8a), 117.1(C-10 and C-4'),
119.3(C-3" and C-5"), 120.1(C-a), 123.5 and
123.6(C-2' and C-4"), 129.2(C-5'), 129.9(C-2" and
C-6"), 130.1(C-6'), 137.8(C-1' and C-l "), 140.0
(C-13), 157.9(C-3'), 158.0(C-9), 158.8(C-I0a),
163.4(C-4b) and I92.5(C=O); IR: 2950, 1640,
1600, 1160, 1120, 980, 915 and 790 em"; UV:
209, 305(8h) and 355 nm.
9-Hydroxy-2, 2, 6, 6-tetramethyl-l0-(3'-nitro-
cinnamoyl)-tetrahydrobenzo[l, z-s. 3, 4- b']di-
pyran 17. Mp 208-09°C; ElMS (reI. int.): m/z
437(M+, 100),407(27),382(79),366(31),326(46),
315(34), 259(26), 217(22), 177(69), 109(21),
83(46) and 69(53); IH NMR: 0 1.35 and 1.45(2s,
6H each, 4xCH3), 1.77-1.84(m, 4H, H-3 and H-7),
2.56(t, J = 6.8, 2H, H-4), 2.65(t, J = 6.8, 2H, H-8),
7.60(m, IH, H-5'), 7.75(d, J = 15.5, IH, H-a),
7.86(d, J= 8.0, IH, H-6'), 8.22(m, 2H, H-4' and H-
(3), 8.52(8, IH, H-2') and 14.32(8, IH, chelated
OH); IR: 2950, 1640, 1600, 1540, 1145, 1105,
970,865 and 720 ern"; UV: 215, 285 and 350 nm.
9-Hydroxy-lO-(3'- benzyloxy-4'- methoxycin-
namoyl)-2, 2, 6, 6-tetramethyl-tetrahydrobenzo-
[1,2-b: 3,4-b']dipyran 18. Mp 118°C; ElMS (reI.
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int.): mlz S28(~, 19), SII(4), 343(9),332(20),
317(12), 316(8), 289(10), 2SS(16), 91 (72) and
43(100); IH NMR: 8 1.34 and 1.41(2s, 6H each,
4xCH3), 1.7S-1.81(m, 4H, H-3 and H-7), 2.S7(t, J
= 6.8, 2H, H-4), 2.62(t, J = 6.8, 2H, H-8), 3.92(s,
3H, OCH3), S.IS(s, 2H, OCH2Ph), 6.92(d, J= 8.0,
IH, H-S'), 7. 19-7.46(m, 7H, H-2', H-6' and OC6Hs),
7.63(d, J = IS.S, IH, H-a), 7.92(d, J = lS.S, IH,
H-~) and 14.SS(s, 1H, ehelated OH); l3C NMR:
8 16.1 and 16.S(C-3 and C-7), 26.9( 4xCH3), 31.8
and 32.0(C-4 and C-8), S6.0(OCH3), 71.0(OCH2),
7S.3 and 7S.8(C-2 and C-6), 100.3 and 100.6(C-4a
and C-8a), 10S.4(C-I0), 111.7(C-2'), 113.0(C-S'),
122.8(C-a), 126.4(C-6'), 127.2(C-3" and C-S"),
127.9(C-4"), 128.S(C-2" and C-6"), 129.0(C-l'),
136.7(C-1 "), 141.0(C-~), 148.4(C-4'), IS1.4(C-9),
lS4.0(C-I0a), IS8.4(C-4b), 163.3(C-3') and
192.S(C=O); IR : 344S, 293S, 236S, 1620, lS10,
1260, 1160, 1120, 990 and 810 ern"; UV : 210,
280 and 370 nm.
1-(2'- Hydroxy-5' - benzhydryl- 4' - methoxy-
pbenyl)-3-( 4-etboxy-pbenyl)propenone 20. Mp
183-8SoC; EIMS (reI. int.): m/z 464(M\ 100),
343(8), 316(38), 239(21), 16S(14), 148(76),
120(22) and 91(23); IH NMR: 8 1.43(t, J = 6.7,
3H, OCH2CH3), 3.7S(s, 3H, OCH3), 4.07(d, J =
6.7, 2H, OCH2), S.77[s, 1H, CH(Ph)2)], 6.46(s, IH,
H-3'), 6.88(d, J= 8.2, 2H, H-3 and H-S), 6.97(d, J
= IS.S, 1H, H-a), 7.10-7.39(m, 13 H, H-2, H-6', H-
6 and 2xC6Hs), 7.67(d, J = lS.S, 1H, H-~)
and 13.39(s, IH, ehelated OH); l3C NMR:
8 14.6 (CH2CH3), 49.S[CH(Ph)2]' SS.7(OCH3),
63.6(OCH2), 99.S(C-3'), 113.2(C-l'), 114.8(C-3
and C-S), 117.8(C-a), 124.2(2xC-1 "), 126.2(2xC-
4"), 127.3(C-1), I28.2(2xC-3" and C-S"), 129.1
(2xC-2" and C-6"), 130.0(C-2 and C-6), 131.S(C-
6'), 143.4(C-S'), 143.6(C-~), 161.0(C-2'), 163.6(C-
4), 16S.4(C-4') and 191.8(C=O); IR: 29S0, 1640,
1610, lS60, 1280, 124S, 1160, 1110, 1040, 990,
840 and 700 ern"; UV: 204,216 and 281 nm.
1-(2' - Hydroxy-5' - benzhydryl-4' - metboxy-
pbenyl)- 3 - (3 - pbenoxypbenyl)propenone 21.
Gummy mass; EIMS (reI. int.): m/z S12(~, 27),
Sll(6), 343(13), 332(28), 317(17), 316(11),
289(14), 2SS(22) and 91(100); IH NMR: 83.7S(s,
3H, OCH3), S.74[s, 1H, CH(Ph)2], 6.4S(s, 1H, H-
3'), 7.00-7.39(rn, 21H, H-a, H-2,H-4,H-S,H-6,H-6'
and 3xC6Hs) and 7.64(d, J = IS.6, 1H, H-~);
l3C NMR : 8 49.6[CH(Ph)2], SS.9(OCH3), 99.6(C-
3'), 113.2(C-l'), 118.l(C-4), 121.0(C-2), 121.3(C-
a), 123.S(2xC-1 "), 123.6(2xC-4"), 126.3(C-3'" and
C-S"') 128.3(C-6), 129.2(2xC-3" and C-S"), 129.4
(2xC-2" and C-6"), 129.8(C-1), 129.9(C-2111and C-
6111),130.2(C-6'), 131.8(C-S'), 132.0(C-S), 136.7(C-
4"'), 142.9(C-~), lS7.l(C-1111)\ IS7.6(C-3), 164.0
(C-2'), 16S.S(C-4') and 191.8(C=O).
1-(2'-Hydroxy-5'-benzbydryl-4'-metboxypbe-
nyl)-3-(3-nitropbenyl)propenone 22. Mp 169-
170°C; ElMS (rel. int.): mlz 46S(M+, 100),
448(73), 43S(16), 388(23), 343(24), 317(10),
289(13),239(19), 16S(20) and 91(S8); IH NMR: 8
'3.77(s, 3H, OCH3), S.77[s, 1H, CH(Ph)2], 6.48(s,
1H, H-3'), 7.10-7.34(m, I2H, H-a, H-6' and
2xC6Hs), 7.S7(t, IH, H-S), 7.67-7.73(m, 2H, H-6
and H-~), 8.2S-8.27(m, 2H, H-2 and H-4) and
13.06(s, IH, ehelated OH); l3C NMR: 8
49.7[CH(Ph)2], S6.0(OCH3), 99.6(C-3'), 121.7(C-
a), 123.3(C-2 and 2xC-I "), 124.S(C-4), I24.6(C-
I'), 126.S(2xC-4"), 128.3(2xC-3" and C-S"),
129.2(2xC-2" and C-6"), 129.9(C-S), 131.7(C-6
and C-S'), 134.S(C-6'), 137.0(C-1), 140.4(C-~),
143.2(C-3), 164.2(C-2'), 166.0(C-4') and
19-1.0(C=O); IR: 29S0, 1640, IS80, lS40, 1280,
1210, 1110, 980, 800 and 700 ern"; UV : 206, 270,
300 and 360 nm.
1-(3',4' -Dimethoxypbenyl)-3-(2-metbylpbenyl)-
propenone 23. Mp 80-81°e; ElMS (rel, int.): mlz
282(M+, 88), 267(72), 2S1 (29-), 16S(100), lS1 (92),
14S(3S), 138(S9), 133(22), 11S(80), 91(49), 79(46)
and 77(34); IH NMR: 8 2.48(s, 3H, CH3), 3.96(s,
6H, 2xOCH3), 6.92(d, J = 8.1, 1H, H-5'), 7.24-
7.31(m, 4H, H-3, H-4, H-S and H-6), 7 .46( d, J =
15.S, 1H, H-a), 7.62(d, J= 2.2, 1H, H-2'), 7.68(dd,
J= 8.1 and 2.2, 1H, H-6') and 8.10(d, J= lS.S, 1H,
H-~); l3C NMR: 8 19.8(CH3), 56.0(2xOCH3),
110.0 and 110.1(C-2' and C-S'), 123.0(C-a),
126.3(C-6 and C-6'), 130.0(C-4 and C-S), 130.9(C-
3), 131.4(C-l'), 134.2(C-l), 138.2 (C-2), 141.6(C-
~), 149.3(C-3'), IS3.3(C-4') and 188.6(C=O); IR :
29S0, 1680, 1600, lS40, 13S0, 1280, 1170, 1040,
1000 and 780 ern"; UV: 207, 233 and 330 nm.
1-(3',4' -Dimetboxypbenyl)-3-( 4-methylphenyl)-
propenone 24. Mp 97-98°C; EIMS (reI. int.): mlz
282(~, 100), 267(S6), 2S1(41), 16S(4S), 14S(32),
137(20), I1S(44) and 91(39); IH NMR: 82.39(s,
3H, CH3), 3.96(s, 6H, 2xOCH3), 6.92(d, J = 8.1,
1H, H-S'), 7.22(d, J= 8.0, 2H, H-3 and H-S), 7.47-
7.SS(m, 3H, H-a, H-2 and H-6), 7.62(d, J = 2.0,
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IH, H-2'), 7.67(dd, J= 8.1 and 2.0, IH, H-6') and
7.78(d, J = 15.6, IH, H-I3); I3C NMR: 0 21.5
(CH3), 56.1 (2xOCH3), 110.1(C-2'), 110.8(C-5'),
120.8(C-a), 122.9(C-6'), 128.3(C-3 and C-5),
I29.4(C-4), 129.7(C-2 and C-6), 131.5(C-l '),
132.4(C-l), 140.8(C-3'), 144.0(C-I3), 153.2(C-4')
and 188.7(C=O); IR: 2950, 1660, 1580, 1520,
1230, 1140, 1015, 980, 800 and 720 em"; UV:
205, 235 and 330 nm.
1-(3' , 4'- Dimetboxypbenyl)- 3-(4- isopropyl-
pbenyl)propenone 25. Yellow gummy mass;
ElMS (reI. int.): mlz 310(M\ 93), 295(32),
279(36), 267(100) 165(68), 131(20), 105(20),
91(36) and 77(29); IH MNR : 8 1.27(d, J = 6.8,
6H, 2xCH3), 2.96[m, IH, CH(CH3)2], 3.95(s, 6H,
2xOCH3), 6.92(d, J = 8.1, IH, H-5'), 7.27(d, J =
8.1, 2H, H-3 and H-5), 7.57-7.59(m, 3H, H-a, H-2
and H-6), 7.62(d, J = 2.1, IH, H-2'), 7.67(dd, J =
8.1 and 2.1, IH, H-6') and 7.79(d, J= 15.5, IH, H-
(3); I3C NMR: 8 23.7(2xCH3), 33.9[CH(CH3)2],
55.9(2xOCH3), 109.9(C-2'), IIO.8(C-5'), 120.7(C-
6'), 122.8(C-a), 126.4(C-l), 126(C-3 and C-5),
128.3(C-2 and C-6), 131.4(C-4), 132.6(C-I '),
143.9(C-I3), 149. 1(C-3'), 151.6(C-4') and 189.0
(C=O); IR: 2960, 1655, 1600, 1510, 1270, 1160,
1025 and 760 cm'; UV: 207,230 and 330 nm.
1-(3', 4' -Dimetboxypbenyl)-3-( 4-etboxypbenyl)-
propenone 26. Mp 87°C; ElMs (reI. int.): mlz
312(M+, 100), 297(18), 283 (43), 281(36),
255(12), 175(16), 165(28), 147(16), 119(20) and
91(19); IH NMR: 8 1.40(t, J = 6.7, 3H,
OCH2CH3), 3.92 and 3.93(2s, 3H each, 2xOCH),
4.04(q, J = 6.7, 2H, OCH2CH3), 6.87(m, 3H, H-3,
H-5 and H-5'), 7.39(d, J= 15.6, IH, H-a), 7.56(d,
J = 8.1, 2H, H-2 and H-6), 7 .59( d, J = 2.2, IH, H-
2'), 7.64(dd, J = 8.1 and 2.2, 1H, H-6') and 7.75(d,
J = 15.6, IH, H-(3); I3C NMR: 8 14.6(CH3),
55.9(2xOCH3), 63.5(OCH2), 109.9(C-2'), IIO.8(C-
5'), 114.8(C-3 and C-5), 119.2(C-6'), I22.7(C-a),
127.6(C-I'), 130.0(C-2 and C-6), 131.6(C-l),
143.8(C-I3), 149.1(C-3'), 153.8(C-4'), 160.8(C-4)
and 188.5(C=O); IR : 2950, 1645, 1600, 1580,
1520, 1335, 1260, 1160, 1040, 920, 810 and 720
em"; UV: 205,235 and 350 nm.
1-(3', 4 '-Dimetboxypbenyl)-3-( 4-nitropbenyl)-
propenone 27. Mp 171°C; ElMS (reI. int.): mlz
313(M+, 100), 298(9), 285(29), 283(38), 252(11),
165(84), 137(12) and 69(29); IH NMR: 8 3.98(s,
6H, 2xOCH3), 6.94(d, J= 8.2, IH, H-5'), 7.62(d, J
= 2.4, IH, H-2'), 7.67-7.99(m, 5H, H-a, H-I3, H-2,
H-6 and H-6') and 8.26(d, J= 8.2, 2H, H-3 and H-
5); I3C NMR: 8 56.0(2xOCH3), 110.0(C-2'),
11O.8(C-5'), 123.3(C-6'), 124.1(C-2 and C-6),
125.5(C-a), 128.8(C·3 and C-5), 129.7(C-l'),
130.7(C-l), 140.6(C-I3), 148.2(C-4), 150.0(C-3'),
153.8(C-4') and 187.6(C=O); IR: 2950, 1645,
1600, 1580, 1520, 1345, 1260, 1240, 1140, 1100,
1010, 840, 810 and 760 ern"; UV: 205, 215 and
315 nm.
1-(3', 4' -Dimetboxypbenyl)-3-(3...;metbylpbenyl)-
propenone 28. Mp 104°C; ElMS (reI. int.): mlz
282(~, 100),267(64),254(10),251(26),239(10),
165(41), 145(15), 115(20) and 91(26); IH NMR: 8
2.41(s, 3H, CH3), 3.97 and 3.98(2s, 3H each,
2xOCH3), 6.93(d, J= 8.2, IH, H-5'), 7.24-735(m,
2H, H-4 and H-5), 7.64(d, J= 2.1, IH, H-2), 7.47-
7.58(m, 2H, H-6 and H-a), 7.65(d, J= 2.1, IH, H-
2'), 7.70(dd, J= 8.2 and 2.1, IH, H-6') and 7.80(d,
J = 15.5, IH, H-I3); I3C NMR: 8 21.2(CH3),
55.9(2xOCH3), 109.9(C-2'), 110.8(C-5'), 121.4(C-
a), 122.9(C-6'), 125.4(C-6), 128.7(C-2), 128.9(C-
4), 131.0(C-3), 131.3(C-l'), 134.9(C-l), 138.4(C-
5), 144.0(C-I3), 149.2(C-3'), 153.2(C-4') and
188.4(C=O); IR: 2950, 1660, 1580, 1510, 1330,
1280, 1240, 1160, 1020, 850, 780, 720 and 680
ern"; UV: 215, 240 and 330 nm.
1-(3',4'-Dimetboxypbenyl)-3-( 4-metboxypbenyl)-
propenone 29. Mp 88°C(lit.44 89°C); ElMS (reI.
int.): mlz 298(M+, 100),283(34),267(46),255(18),
165(26), 161(23), 133(16) and 79(16); IH NMR:
83.83,3.94 and 3.96(3s, 3H each, 3xOCH3), 6.89-
6.94(m, 3H, H-3, H-5 and H-5'), 7.42(d, J = 15.5,
IH, H-a), 7.59(d, J = 8.1, 2H, H-2 and H-6),
7.61(d, J= 2.1, IH, H-2'), 7.66(dd, J= 8.1 and 2.1,
IH, H-6') and.7.77(d, J = 15.5, IH, H-I3); I3C
NMR: 8 55.3 and 56.0(3xOCH3), 11O.0(C-2'),
11O.9(C-5'), 114.3(C-3 and C-5), 119.4(C-6'),
122.8(C-a), 127.8(C-l '), 130.0(C-2 and C-6),
131.6(C-l), i43.7(C-I3), 149.5(C-3'), 153.2(C-4'),
161.5(C-4) and 189.0(C=O); IR: 2950, 1660, 1600,
1575, 1520, 1300, 1240, 1160, 1015, 795 and 720
ern"; UV: 205, 235 and 350 nm.
1-(3', 4' -Dimetboxypbenyl)-3-(3,4-dimetboxy-
pbenyl)propenone 30. Mp 110°C (lit.45 106-
08°C); ElMS (reI. int.): mlz 328(M\ 88), 313(38),
297(38), 191(19), 165(20) and 91(100); IH NMR:
83.94,3.95,3.96 and 3.97(4s, 3H each, 4xOCH3),
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1H, H-2), 7.24(dd, J = 8.1 and 2.2, 1H, H-6),
7.40(d, J= 15.5, IH, H-a), 7.62(d, J= 2.1, IH, H-
2'), 7.68(dd, J= 8.1 and 2.1, IH, H-6') and 7.76(d,
.J = 15.5, IH, H-I3); \3C NMR: 0 56.0(4xOCH3),
109.9(C-2'), 110.3(C-2), 110.9(C-5'), 111.1 (C-5),
119.7(C-a), 122.8(C-6 and C-6'), 128.0(C-l'),
131.5(C-l), 144.0(C-I3), 149.2(C-3 and C-3'),
151.2(C-4'), 153.1(C-4) and 188.6(C=0); IR:
2950, 1665, 1610, 1580, 1520, 1320, 1260, 1240,
1150, 1020,850,800, 760 and 710 ern"; UY: 205,
240 and 360 nm.
1-(3', 4'-Dimethoxyphenyl)-3-(3-phenoxyphenyl)-
propenone 3146. Yellow gummy mass; ElMS (reI.
int.): mlz 360(M+, 100), 345(5), 329(23), 267(37),
223(11), 165(74), 102(21) and 91(36); IH NMR: 0
3.96(s, 6H, 2xOCH3), 6.92(d, J = 8.0, IH, H-5'),
7.02-7.38(m, 9H, H-2, H-4, H-5, H-6 and C6H5),
7.49(d, J = 15.5, 1H, H-a), 7.60(d, J = 2.0, 1H, H-
2'), 7.65(dd, J= 8.0 and 2.0, IH, H-6') and 7.74(d,
J = 15.5, 1H, H-I3); \3C NMR: 0 56.0(2xOCH3),
110.0(C-2'), 111.5(C-5'), 118.5(C-6'), 119.3(C-2"
and C-6"), 120.4(C-4), 121.1(C-2), 121.6(C-5),
122.2(C-a), 122.6(C-6), 129.1(C-3" and C-5"),
129.4(C-4 "), 132.0(C-l '), 136.8(C-l), 142.1 (C-I3),
149.8(C-3'), 153.2(C-4'), 156.1(C-3), 157.3(C-l")
and 188.2(C=0).
1-(2' -Benzyloxy-4' -methoxyphenyl)-3-phenyl-
propenone 32. Mp 105-06°C (lit.42 105-06°C);
ElMS (reI. int.): mlz 344(M+, 56), 253(62),
225(64), 198(19), 164(17), 151(49), 103(18),
91(100) and 77(20); IH NMR: 0 3.86(s, 3H,
OCH3), 5.13(s, 2H, OCH2Ph), 6.58(s, IH, H-3'),
7.25-7.50(m, 13H, H-5', H-6', H-a and 2xPh) and
7.86(d, J = 15.5, IH, H-I3); \3C NMR: 0
56.2(OCH3), 72.4(OCH2), 100.3(C-3'), 106.7(C-
5'), 123.7(C-l '), 127.3(C-a), 127.8(C-3 and C-5),
128.0(C-4 and C-4"), 128.2(C-3" and C-5"),
128.9(C-2" and C-6"), 129.8(C-2 and C-6),
134.7(C-6'), 135.5(C-l "), 135.9(C-l), 142.3(C-I3),
160.5(C-4'), 164.7(C-2') and 190.1 (C=O); IR:
2950, 1640, 1620, 1580, 1280, 1250, 1160, 1120,
1010,820 and 720 em"; UV: 205, 210(sh) and 305
nm.
1-(2', 4' -Dihydroxyphenyl)-3-( 4-methylphenyl)-
propenone 33. Mp 149°C(lit.47 153-54°C); ElMS
(reI. int.): mlz 254(~, 100), 239(28), 163(70),
137(63), 118(59) and 91(19); IH NMR: 0 2.40(s,
3H, CH3), 5.70(brs, IH, OH), 6.42(m, 2H, H-3' and
H-5'), 7.22(d, J = 8.1, 2H, H-3 and H-5), 7.52-
7.56(m, 3H, H-a, H-2 and H-6), 7.81-7.90(m, 2H.
H-13 and H-6') and 13.38(s, IH, chelated OH):
\3C NMR: 0 21.5(CH3), 103.7(C-3'); 107.8(C-5'),
119.2(C-a), 128.6(C-3 and C-5), 129.8(C-2 and C-
6), 131.9(C-l and C-6'), 132.0(C-l'), 141.3(C-4),
144.8(C-I3), 164.4(C-2'), 166.5(C-4') and 192.0
(C=O); IR: 2950, 1650, 1615, 1570, 1520, 1300,
1220, 1140, 1020, 980, 840 and 800 ern"; UV:
205, 220(sh) and 355 nm.
X-Ray crystallography. The crystallographic
measurements were made using either a Siemens
P3R3 four-circle diffractometer (for compounds 14
and 23) or a Siemens SMART area-detector
diffractometer (for compounds 19 and 29),
Graphite monochromated Mo-Ka radiation "as
used in all cases. The structures were solved using
SHELXTL-PLUS54 and refined with SHELXL-
9655. The crystal data of compounds 14, 19,23 and
29 are given below.
Compound 14. C26H3004, M = 406.50, T =
220(2) K, A = 0.71073 A. Monoclinic a= 7.930(8),
b =17.69(2), c = 16.101(13) A, 13= 102.85(7t,
V = 2203(4) A3, space group P2/n, Z = 4, Dx =
1.226 mg/rrr', /..l =0.081 mrn', F(OOO) = 872.
Crystal size 0.23 x 0.16 x 0.14 mm; e range for
data collection 1.73-24.05°; index ranges 0 < h < 9,
-I < k < 20, -18 < I < 18; reflections collected
4024; independent reflections 3477 [R(int) =
0.1 185]; refinement method full-matrix least
squares on F2; data/restraints/parameters
3468/1/278; goodness-of-fit on F2 1.05; R(F) [I >
20'(1)] = 0.080, wR(F2) = 0.247; largest diff. peak
and hole 0.30 and -0.39 eA-3.
Compound 19. C22H2405, M = 368.41, T =
180(2)K, A = 0.71073A. Monoclinic a =
16.04270(10), b = 7.4619(2), c = 16.9082(3) A,
13= 109.88°, V= 1903.43(6) N, space group P21/c,
Z = 4, D, = 1.286 mg/rrr', /..l = 0.090 mm", F(OOO)
= 784. Crystal size 0.60 x 0.20 x 0.20mm; e range
for data collection 2.46 to 28.57°; index ranges -20
< h < 12, -10 < k < 9, -19 </< 22; reflections
collected 11080; independent reflections 4431
[R(int) = 0.0442]; refinement method full-matrix
least squares on F2; data! restraints/parameters
4431111248; goodness-of-fit on F2 0.966; R(F)
[I > 20' (I)] = 0.0551, wRCF2) = 0.1070; largest dit.
peak and hole 0.198 and -0.204ek3
Compound 23. C18H1803, M = 282.32, T =
642 INDIAN J CHEM, SEC.B, JULY 1998
210(2) K, ')..=0.71073 A. Triclinic a= 11.160(5),
b =11.278(6), c = 13.829(6) A, a = 98.01(4),
J3 = 108.89(4), Y = 105.50(4t, V = 1537.4(13) A3,
space group P-1, Z = 4, D, = 1.220 mg/rrr',
J..L=0.082 mm", F(OOO) = 600. Crystal size
0.41 x 0.30 x 0.16 mm; e range for data collection
1.61-23.050; index ranges 0 < h < 12, -12 < k < 11,
-15 </< 14; reflections collected 4551; inde-
pendent reflections 4294 [R(int)=0.059]; refine-
ment method full-matrix least squares on F2; datal
restraints/ parameters 4292/2/389; goodness-of-fit
on F2 0.978; R(F) [I > 2cr(l)] = 0.071, wR(F2) =
0.227; largest diff. peak and hole 0.25 and -0.36
eA,3.
Compound 29. CIsHIS04, M = 298.32, T =
210(2) K, ')..= 0.71073 A.. Triclinic a= 8.7639(5),
b = 8.9206(4), c = 11.3537(6) A, a = 107.969(2),
J3 = 102.295(2), y = 106.4820(10t, V = 764.44(7)
N, space group P-l, Z = 2, D, = 1.296 mg/rrr',
J..L=0.091mm", F(OOO) = 316. Crystal size
0.36 x 0.23 x 0.07mm; e range for data collection
2.00-23.30°; index ranges -9 < h < 9, -9 < k < 8, -
12 </< 10; reflections collected 3428; independent
reflections 2174 [R(int) = 0.055]; refinement
method full-matrix least squares on F2; datal
restraints/parameters 2170/0/202; goodness-of-fit
on F2 1.15; R(F) [I > 2cr(I)] = 0.066, wR(F2) = 21
0.1754; largest diff. peak and hole 0.22 and -0.24
eA,3.
Complete atomic coordinates, thermal 23
parameters and bond angles have been deposited at 24
the Cambridge Crystallographic Data Centre. 25
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